Tuberculosis Flashcards

1
Q

What is TB

A

a contagious, debilitating (consuming) bacterial disease
spread by airborne droplets from an infected person

Caused by a bacterium
Mycobacterium tuberculosis
slow growing, difficult to kill, waxy coat
coughing speaking sneezing
Left untreated, one person with tuberculosis
will infect 10-15 people per year

TB has tissue destruction producing holes/cavitiies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Symptoms of pulmonary TB

A

Early in disease, non-specific and insidious

A cough that will not go away 
Feeling tired all the time 
Weight loss 
Loss of appetite 
Fever 
Night sweats 

Cough - initially non-productive
later is productive
haemoptysis
~ 35% 5-year mortality pre-antibiotics

Clinical illness directly following infection called
Primary tuberculosis

starts as dry cough, as disease progresses you get haemoptysis- blood comes out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ghon complex

A

Initial infection with Mycobacterium tuberculosis in an immunocompetent individual usually occurs in an
upper region of lower lobe of the lung producing a lesion called
a Ghon focus.

Granulomatous involvement of peribronchial and/or hilar lymph nodes is frequent in primary tuberculosis due to lymphangitic spread from the Ghon focus.

The early Ghon focus together with the lymph node lesion constitute the Ghon complex.

These lesions undergo healing and over time usually evolve to fibro-calcific nodules.

Caseous necrotic tissue - constitutes the granulomas in this
gross appearance of a Ghon complex of primary TB.

Most patients with primary tuberculosis are asymptomatic

creamy white are is nectrotic damage- Grohn focus
the lymph node has a cheesy constituency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why is TB the ‘great imitator’

A

‘The great imitator’
TB can infect any part of the body, mimicking other diseases

Extra-pulmonary TB

TB is the great imitiator so can not only affect lungs but any part of body- extrapulmnary TB

extrapulmonary TB

only 30% of people exposed get infected w TB
of 30% of those who get affected, only 5% get the active disease

otherwise you become latent infected- you have microscopic lesions in lower lobes of lung/bone marrow/lymph tissue

we know that from mantoux skin test- inject TB antigens and look for T cell reaction- you get a hypersensitivity reaction if person has bee exposed to TB
latent TB can become active TB if you become HIV positive/diabetic/ cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cellular pathology of TB

A

Cell-mediated delayed type hypersensitivity response (Type IV)

healthy lung: mono layer of cells, alveolar cells, surveillance macrophages etc
right side: someone w pulmonary TB- alveoli obstructed by granuloma .

TB granuloma
spherical collection of lymphocytes, 
macrophages and epithelioid cells 
with a small area of central 
caseation necrosis

Epitheliod like cells (activated macrophages)

The centre of the granuloma undergoes a combination of
liquefaction and coagulative necrosis producing caseous necrosis,
which is unique to TB and causes considerable tissue destruction to the host.
tissue necrosis- all the cells recrutied to the granuloma can become necrotic and lysed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diagnosis of pulmonary TB

A

Chest X ray
CT

Sputum- - cough or induced
- smear, culture, PCR

Bronchoscopy, lavage, biopsy

make smear of TB ousing ZN stain and take PCR of dna from sputum
look for acid fast bacilli
some sort of mycobacterium
set up in culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TB treatment overview and history

A
Started off with just needing 'fresh air'
New way –  antibiotics 
1943 - Selman Waxman  -  Streptomycin
TB rapidly became resistant to 1 drug
10,000,000,000 bacteria mutating DNA

Post- 1973 - 4 drug combination trials – Prof Denny Mitchison
Standard short !! Course - 6 months

Isoniazid  (H)
rifampicin  (R)
pyrazinamide (Z)  
ethambutol (E)

          - >95% effective – relapse rates
          - prevented resistance

TB is unusual in the fact that it has many more bacteria in your body
can exist in HIGH numbers
driving chronic inflammatory immunopathology
so a single antibiotic drives drug resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Intensive vs continuous phase

A

Intensive phase RHZE for 2 months
Continuation phase RH for 4 months

in some cases, treatment lasts longer

e.g.
- patients with cavities on chest x-ray and positive sputum cultures at 2 months
should have treatment extended to 9 months
- Meningeal TB

intensive phase is with all the 4 drugs for 2 months
then in continuation phase you go with R and H for 4 months

9%% effective treatment
might need to treat people longer for sometimes because bacterial load is higher or tissue penetration not good
eg for bone TB

but general pulmonary TB treatment is 6 month therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment rules for TB

A

Treatment must contain multiple drugs to which organisms are susceptible

Treatment with a single drug or adding a single drug to failing regimen can lead to the development of drug-resistant TB

High bacterial load in TB (unique)

Selection of pre-existing resistant mutants

dropping one drug and adding another just adds to resistance
bacterial load is so high so there will naturally be pre exisiting mutants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

TB antibiotics

A

Isoniazid (INH) – inhibits synthesis of mycolic acid, required for mycobacterial cell wall

Rifampicin (RIF) – inhibits bacterial RNA polymerase

Pyrazinamide (PZA) – binds to the ribosomal protein S1 (RpsA) and inhibitstranslation + other possible mechanisms

Ethambutol (EMB) – inhibits arabinosyl transferases involved in cell wall biosynthesis of arabinogalactans

RIF prevents mRNA
all 4 drugs have dif sites of action- they have a synergistic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cell wall inhibition in TB

and how does isoniazid work

A

INH acts on mycolic acids on the membrane
EMB acts on arabinogalactan

Isoniazid is a pro drug 
needs to be activated in bacteria
Activated by catalase peroxidase 
activates enzyme cascade
go through pathway 
eventually inhibits InhA gene
blocking synthesis of myocolic acids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how does pyraminazidase work

A

Conversion of pyrazinamide to its active acid form
pyrazinoic acid by PncA - pryazinamidase (PZase)
enzyme

Pz’ase only active at acid pH
POA - multiple targets – membrane e- potential;
fatty acid synthesis for cell walls
trans-translation
pro drug is only made into its active form as a result of the enzyme pryazinamidase, encoded by PncA

if PcNA gene muates, this pro drug can’t be activated and you become resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why does TB therapy take 6 months

A

M.tuberculosis drug tolerant persisters

tolerant persisters are not generally antibiotic resistant- they are metabollically tolerant
they are longer turning over cell walls or producing certain enzymes

if the bacteria is not expressing the enzyme
the antibitoic is going to have no effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In vitro bactericidal activities of Isoniazid vs M.tuberculosis

A
Log phase
Rapid killing
followed by:
Stationary phase
Slow killing, stasis

if the bacteria don’t go down and stay stationary
you need other drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

LTBI Treatment RegimensIsoniazid or Rifampicin

A

Purpose : to prevent people with latent TB or exposed to TB
from developing disease

Preferred regimen - isoniazid (INH) daily for 9 months (min. 6 mo)

Rifampicin (RIF) – alternative, if:
Cannot tolerate INH
Have been exposed to INH-resistant TB
RIF should be given daily for 4 months
RIF should not be used with certain combinations of anti-retroviral (ARV) therapy

12-dose once-weekly regimen of INH and RPT(long lasting rif)
not if on ARVs or < 12 years old

rifampicin and isoniazid daily for 3-4 months

Why a single drug?
low bacterial load,
low chance of pre-existing mutants

how can we treat latent TB (its non infectious)
isoniazid is good for rapidly killing but not so good at killing resistors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

TB is easy to treat with antibiotics,

so what’s the problem? (resistance)

A

Factors that increase chance of patient having or developing drug-resistant TB:

Patient has spent time with someone with active drug-resistant TB disease
Patient does not take their medicine regularly
Patient does not take all of their medicine
Patient develops active TB disease after having taken TB medicine in the past
Patient comes from area of the world where drug-resistant TB is common

17
Q

How can we show this mutation rate?

A

Spontaneous mutations
develop as bacilli
proliferate to >108

Rifampicin 10 ^-8 mutation rate
Isoniazid 10^-6 mutation rate
Pyrazimide 10^-6 mutation rate

sputum on agar plate
by random selection you have random mutants

M. tuberculosis bacteria become resistant to anti-TB drugs by acquiring mutations that confer resistance. Such mutations develop spontaneously as the bacteria proliferaet in the host.
Rif-R mutants arise at a frequency of 1 in 10exp-8
INH-R and PZA-R mutants arise at a frequency of 10exp-6
So, prior to treatment, the population of bacteria in a TB patient already contains drug-resistant bacteria.

How it happens:
Drug resistant mutants in population
People get monotherapy
Development of isoniazid resistant bacteria
Isonoziad resistant bacteria multiply to 108 and spontaneous mutations develop to rifampicin

Then if we give both isoniazid and rifampicin
Isoniazid monoresistant mutants get killed with addition of rifampicin but rifampicin resistant mutants proliferate
Resulting in MDR TB

18
Q

MDR and XDR TB

A

XDR-TB is MDR-TB that is resistant to any fluoroquinolone and at least one of three injectable second-line drugs (capreomycin, kanamycin, and amikacin)

MDR and XDR TB are treatable
just more difficult
requires the use of “second line” or reserve drugs
more costly
cause more side effects
up to two years
Cure rates ~ 50% to 70%

2 are resistant sowe have to choose 2 others
these other drugs don’t work as well against persistors
they are also more toxic, lengthy and expensive

you can even get multi drug resistance tb
which is resistant to more of these

19
Q

Drug resistance mechanisms

A

Barrier mechanisms (decreased permeability and efflux pump)

degrading or inactivating enzymes (e.g. β- lactamases)

modification of pathways involved in drug activation
or drug metabolism (e.g. katG and isoniazid resistance)

drug target modification (e.g. rpoB and rifampicin resistance)

target amplification (e.g. inhA and isoniazid resistance)

20
Q

Drug resistance testing

A

Conventional – Phenotypic
Using solid and liquid media
Absolute concentration
Time consuming - >2 – 6 weeks

Genetic tests for mutations in target
Rapid
Predictive only
Needs accurate Databases of mutations

eg.
The rifampicin resistance determining region (RRDR) of rpoB
over year people have sequenced rpoB gene and sequenced maps

21
Q

GeneXpert

A

geneXpert test used widely to diagnose TB and identify resistance
real time PCR from sputum
Detects RifR by mutations in rpoB by qPCR

UNITAID: 2014
30% year-on-year increase 
in detection of DRTB,
mostly due to 
the expanded use of 
innovative diagnostics.

M. tuberculosis rifampicin resistance testing:

95% RifampicinR rpoB SNPs in RRDR – codons 507-533
81bp mutation hotspot
Cepheid GeneXpert Rif+ testing – realtime qPCR
Mtb complex specific – use hemi-nested PCR approach

assay has 5 probes
if probe cant bind to sequqence in patient sample
probs doesnt stick 
no fluorescence
tells us drug resistant TB to rifampycin
22
Q

Whole Genome sequencing to test for resistance

A

Lots of genes to test - 900+ mutations in ~50 genes
Lots of drugs for TB treatment

can screen for mutations for multiple drugs
can treat w right antibitoics for mdr or mxr tb

Genotypic tests depend on strength of associations
Difficulties:
	Cross resistance
	no DST data for new SNPs
	?DST and MICs for drugs 
	strain variation
	compensatory and secondary mutations
23
Q

Where are we going with TB treatment

A
New drugs  - bedaquiline, delaminid, BTZ
Better regimens 	- shorter
			- new combinations
			- treat latent TB 
Increase dose ? e.g. rifampicin 30mg/kg
Better resistance testing  - e.g. WGS genotyping

WHO – “3 million cases of TB undetected” !!
- Better diagnostics

24
Q

Try to answer these questions

A

Name the causative agent for tuberculosis (TB)
Briefly describe the pathology of TB.
Explain the rationale for the combination antibiotic treatment for TB
List examples and the site of action of the key antibiotics used to treat TB
Define the terms: MDR-TB and XDR-TB
Explain how and why antibiotic résistance emerges in TB
Describe methods to determine antibiotic resistance for M. tuberculosis
Explain the clinical value of genotype determination of resistance in M.tuberculosis